Candidate:

Dr. Life Scientist

About Me:

May I ask what happens when a trio of Marie Curie, Florence Nightingale, and Indra Nooyi come together? For me, a combination of skills from the above-mentioned accomplished women is something that I want to embody for providing cost-effective ways for innovation in healthcare.

Schools:

Target School: Harvard

Considering: Kellogg SOM, Duke Fuqua, Kenan-Flagler, Kenan-Flagler

See More Profiles For: Harvard

Application Status: Rejected

Details:

Undergrad School: University of Delhi

Undergrad Major: Pharmacy

GPA: 3.98

GRE: 317

Age: 31, Ethnicity: Asian or Indian

Other Degree/Certification: PhD in Pharmacology and Neuroscience

School Name: Southern Illinois University

Extracurriculars: PreScouter Scholar where I have provided competitive intelligence to clients from wide ranging industries, Served as a volunteer at a free clinic for patient intake and drug reconciliation., Catchafire volunteer where I have provided literature review and online research service to non-profit clients.

Work History:

Title: ORISE Technology Transfer Fellow

Industry: Government

Company: Global

Length of Employment: 1 yr

Title: Postdoctoral Research Fellow

Industry: Healthcare

Company: Top Firm In Selected Industry

Length of Employment: 2 yrs, 6 mos

Big Life Wins:

One of my biggest accomplishments have been to have guided my undergraduate mentees and filled them with enthusiasm to pursue a career in life sciences. Another major win for me has been to overcome imposter syndrome and have the courage to chart out a non-conventional career path than most research scientists.

Post MBA Goal:

As my short-term goal post MBA, I see myself as a consultant in strategic planning who resolves issues surrounding discovery, development, and commercialization of therapeutic innovations in pharmaceuticals or biotech area. Another area of my interest is operations management and quality assurance with focus on pharmaceutical, biotech or hospital systems as potential employers. Both paths fit well with my long-term goals of working in regulatory or healthcare policy roles. I have chosen Mendoza College as it provides a very unique combination of learning business curriculum, leadership, analytics, and ethics all of which are very much needed to be a successful leader in today’s world.

Odds:

Join in! Click here to assess the odds of Dr. Life Scientist

See what the industry experts have to say:

John A. Byrne, P&Q Founder & Editor-In-Chief |

So sorry to hear you were released from HBS today. No worries. It’s their loss. It’s worth nothing that there is not a single MBA student at Harvard in the 2020 cohort who has a degree from either the University of Delphi, where you earned your degree in pharmacy, or Southern Illinois University, where you earned your PhD.

Frankly, you had me at “May I ask what happens when a trio of Marie Curie, Florence Nightingale, and Indra Nooyi come together?”

I think your odds are very good at your other target schools, including Kellogg, Duke, UNC and Notre Dame. Obviously, your stretch school among this group is Kellogg which does not disclose average GRE scores. But I think your educational and work history bodes well …

So sorry to hear you were released from HBS today. No worries. It’s their loss. It’s worth nothing that there is not a single MBA student at Harvard in the 2020 cohort who has a degree from either the University of Delphi, where you earned your degree in pharmacy, or Southern Illinois University, where you earned your PhD.

Frankly, you had me at “May I ask what happens when a trio of Marie Curie, Florence Nightingale, and Indra Nooyi come together?”

I think your odds are very good at your other target schools, including Kellogg, Duke, UNC and Notre Dame. Obviously, your stretch school among this group is Kellogg which does not disclose average GRE scores. But I think your educational and work history bodes well for you there. Good luck to you.

5 years ago Read the full review
Sandy Kreisberg, The HBS Guru

Ding at HBS not a super surprise, the 317 GMAT is a real boo-boo and if you are seriously interested in getting a top-tier MBA, I’d take that again (and again). Also reason for MBA is unclear, given Ph D and job history. Your final goal: — “providing cost-effective ways for innovation in healthcare”–is unclear and just part of a do-gooder fog that seems to be your presenting style. As a consultant?
I’d be more down to earth.

Ding at HBS not a super surprise, the 317 GMAT is a real boo-boo and if you are seriously interested in getting a top-tier MBA, I’d take that again (and again). Also reason for MBA is unclear, given Ph D and job history. Your final goal: — “providing cost-effective ways for innovation in healthcare”–is unclear and just part of a do-gooder fog that seems to be your presenting style. As a consultant?
I’d be more down to earth.

5 years ago
mbaMission

Hi Dr. Life Scientist! Sorry to hear about your HBS ding. I suspect your GRE score could have been a big challenge there (their median is 326). Sometimes a non-traditional background can be a plus, and sometimes it can be a challenge, depending on how compelling your story is and how clear your goals and reasons for the MBA are. I like the ambition and inspiration you show in your post, but it is a bit light on concrete details. I think Kellogg could also be tough for you, unless you’re able to raise your GRE, but I feel more hopeful about your chances at Kenan-Flagler and Mendoza. Good luck!

Hi Dr. Life Scientist! Sorry to hear about your HBS ding. I suspect your GRE score could have been a big challenge there (their median is 326). Sometimes a non-traditional background can be a plus, and sometimes it can be a challenge, depending on how compelling your story is and how clear your goals and reasons for the MBA are. I like the ambition and inspiration you show in your post, but it is a bit light on concrete details. I think Kellogg could also be tough for you, unless you’re able to raise your GRE, but I feel more hopeful about your chances at Kenan-Flagler and Mendoza. Good luck!

5 years ago